Roger J. Pomerantz, MD, FACP

Examiner
DISC Type : cs

Member Board of Directors at 1E Therapeutics

New York City Metropolitan Area, United States

Overview

Roger serves on multiple biotech boards, leveraging his expertise in infectious diseases. With a background from Harvard Medical School and MIT, he has led the development of 14 approved drugs for HIV, HCV, and TB, and has completed over 160 business development and licensing deals in leadership roles at Merck and Johnson & Johnson.

He played a pivotal role in developing some of the first successful treatments for both HIV and Hepatitis C, fundamentally changing the course of those diseases.

Personality Overview

Overcautious

Unexpressive

Process Oriented

The only way to convince them is by showing them examples and ample proof.  They are heavily focused on quality and prefer doing things the right way, even if it takes time. Being observant comes to them naturally.

Topics They Care About

Infectious Disease Cures
His entire career has focused on developing novel treatments for diseases like HIV, HCV, and C. diff, holding global head of infectious disease roles at Merck and J&J.
Biotech Board Leadership
Serves as Chairman or board member for numerous public biotech companies, including Indaptus Therapeutics, CollPlan, Viracta, and 1E Therapeutics, guiding their strategic direction.
Microbiome Medicine
He was the founding Chairman, President, and CEO of Seres Therapeutics, the first publicly traded microbiome therapeutics company.

Media Appearances

CollPlant Announces Appointment of Roger J. Pomerantz, M.D.. Featured in CollPlant

See Now

Work History

4-2025
Member Board of Directors at 1E Therapeutics
8-2021
Founding Chairman of the Board of Directors at Indaptus Therapeutics Inc.
2-2020
Chairman Of The Board Of Directors at CollPlant
12-2019
Senior Clinical Advisor to the Board of Directors at Seres Therapeutics
9-2013 - 12-2019
Founding Chairman of the Board of Directors at Seres Therapeutics

Education

1987 - 1988
Chief Resident from Harvard Medical School - Massachusetts General Hospital
1988 - 1990
Post Doctoral Fellowship - Whitehead Institute of Biomedical Research of MIT from Massachusetts Institute of Technology

More Information

Social Presence :

Prographics :

Exp : 11 Location : New York City Metropolitan Area, United States Job Level : N/A Designation : Member Board of Directors at 1E Therapeutics
URL has been copied!

Insights For Selling To Roger J.

During A Call Or A Meeting

DO's

  • Expect them to be vague in response to your questions, ask firmly and pointedly
  • Ask them which other stakeholders would be important for this purchase decision
  • Spend time addressing concerns around risk and change, they will have them even if they don't express them

DONT's

  • Don't rely on relationship building even if they act pleasantly
  • Don't be very accepting if that is your natural style, stay firm
  • Avoid getting into storytelling mode, especially when they ask specific questions

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Roger J. is

  • Adoption by others is very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Roger J.

  • They are unlikely to say no, it's better to stop yourself once you have exhausted all the options.

Insights For Deal Planning

    How fast (or slow) will Roger J. move?

  • They don't like to hasten, so their speed of decision-making may be slow.
  • Can Roger J. take some risk or not?

  • They have little willingness to take risks, and prefer making calculated decisions.

You And Roger J.

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.